Effectiveness of a Smartphone App With a Wearable Activity Tracker in Preventing the Recurrence of Mood Disorders: Prospective Case-Control Study

Chul-Hyun Cho, Taek Lee, Jung-Been Lee, Ju Yeon Seo, Hee-Jung Jee, Serhim Son, Hyonggin An, Leen Kim, Heon-Jeong Lee, Chul-Hyun Cho, Taek Lee, Jung-Been Lee, Ju Yeon Seo, Hee-Jung Jee, Serhim Son, Hyonggin An, Leen Kim, Heon-Jeong Lee

Abstract

Background: Smartphones and wearable devices can be used to obtain diverse daily log data related to circadian rhythms. For patients with mood disorders, giving feedback via a smartphone app with appropriate behavioral correction guides could play an important therapeutic role in the real world.

Objective: We aimed to evaluate the effectiveness of a smartphone app named Circadian Rhythm for Mood (CRM), which was developed to prevent mood episodes based on a machine learning algorithm that uses passive digital phenotype data of circadian rhythm behaviors obtained with a wearable activity tracker. The feedback intervention for the CRM app consisted of a trend report of mood prediction, H-score feedback with behavioral guidance, and an alert system triggered when trending toward a high-risk state.

Methods: In total, 73 patients with a major mood disorder were recruited and allocated in a nonrandomized fashion into 2 groups: the CRM group (14 patients) and the non-CRM group (59 patients). After the data qualification process, 10 subjects in the CRM group and 33 subjects in the non-CRM group were evaluated over 12 months. Both groups were treated in a similar manner. Patients took their usual medications, wore a wrist-worn activity tracker, and checked their eMoodChart daily. Patients in the CRM group were provided with daily feedback on their mood prediction and health scores based on the algorithm. For the CRM group, warning alerts were given when irregular life patterns were observed. However, these alerts were not given to patients in the non-CRM group. Every 3 months, mood episodes that had occurred in the previous 3 months were assessed based on the completed daily eMoodChart for both groups. The clinical course and prognosis, including mood episodes, were evaluated via face-to-face interviews based on the completed daily eMoodChart. For a 1-year prospective period, the number and duration of mood episodes were compared between the CRM and non-CRM groups using a generalized linear model.

Results: The CRM group had 96.7% fewer total depressive episodes (n/year; exp β=0.033, P=.03), 99.5% shorter depressive episodes (total; exp β=0.005, P<.001), 96.1% shorter manic or hypomanic episodes (exp β=0.039, P<.001), 97.4% fewer total mood episodes (exp β=0.026, P=.008), and 98.9% shorter mood episodes (total; exp β=0.011, P<.001) than the non-CRM group. Positive changes in health behaviors due to the alerts and in wearable device adherence rates were observed in the CRM group.

Conclusions: The CRM app with a wearable activity tracker was found to be effective in preventing and reducing the recurrence of mood disorders, improving prognosis, and promoting better health behaviors. Patients appeared to develop a regular habit of using the CRM app.

Trial registration: ClinicalTrials.gov NCT03088657; https://ichgcp.net/clinical-trials-registry/NCT03088657.

Keywords: circadian rhythm; digital therapeutics; mood disorder; recurrence prevention; smartphone app; wearable activity tracker.

Conflict of interest statement

Conflicts of Interest: None declared.

©Chul-Hyun Cho, Taek Lee, Jung-Been Lee, Ju Yeon Seo, Hee-Jung Jee, Serhim Son, Hyonggin An, Leen Kim, Heon-Jeong Lee. Originally published in JMIR Mental Health (http://mental.jmir.org), 05.08.2020.

Figures

Figure 1
Figure 1
Comparison of the distributions of changes in individual features after receiving warning alerts in the CRM and non-CRM groups. The vertical axis refers to the delta of gradient change (DGC). If the median of the box plot (the green horizontal line inside the box) is near zero, this means that there was no significant change in the feature before and after the warning alert. If the median is greater than zero, this means that the feature value tended to increase after the alert. If it is less than zero, this means that the feature value tended to decrease after the alert. For example, if a patient with low activity during the day received a warning alert and the median of the distribution of the DGC value outcome for the feature steps_during_daytime moves in a positive direction, then we can assume that the patient tried to increase their activity. To compare the DGC distributions of the CRM group and non-CRM group for key features related to the H-score, DGCs were calculated based on each of the time points t at which alarms were activated during the experiment. The system logs for the warning alert calculations recorded the past feedback point t of the alert receivers. The actual warning alert was not delivered to the non-CRM group at time t but delivered only to the subjects in the CRM group at time t. In the comparison analysis, patients whose features could not be calculated due to a lack of data were omitted. CRM: Circadian Rhythm for Mood; KST: Kolmogorov-Smirnov test; MWT: Mann-Whitney U test.
Figure 2
Figure 2
Changes in the Fitbit wearing rate in the CRM and non-CRM groups. A moving average technique was used to report the trend lines by abbreviating the raw time series data (window size=6 days). The time unit on the horizontal axis is 30 days, which means that the number of total wearing hours for 30 days was measured and plotted at each time point. The thin solid lines on the top area are individual trend lines of the change in the Fitbit wearing rate of each patient, and the thick solid line is an average trend line of the individual lines. The lines in the bottom area are the standard deviation trend line (MSD) of the change in the wearing rate. Increasing moving average and decreasing MSD might be positive.

References

    1. Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004 Mar 23;49(2):124–38. doi: 10.1177/070674370404900208.
    1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jul 01;62(6):593–602. doi: 10.1001/archpsyc.62.6.593.
    1. Kessler RC, Akiskal HS, Ames M, Birnbaum H, Greenberg P, Hirschfeld RMA, Jin R, Merikangas KR, Simon GE, Wang PS. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry. 2006 Oct;163(9):1561–8. doi: 10.1176/ajp.2006.163.9.1561.
    1. Rihmer Z. Suicide risk in mood disorders. Current Opinion in Psychiatry. 2007;20(1):17–22. doi: 10.1097/yco.0b013e3280106868.
    1. Simon GE. Social and economic burden of mood disorders. Biological Psychiatry. 2003 Aug;54(3):208–215. doi: 10.1016/s0006-3223(03)00420-7.
    1. Goldberg JF, Harrow M, Grossman LS. Recurrent affective syndromes in bipolar and unipolar mood disorders at follow-up. Br J Psychiatry. 1995 Mar 02;166(3):382–5. doi: 10.1192/bjp.166.3.382.
    1. Angst J, Gamma A, Sellaro R, Lavori PW, Zhang H. Recurrence of bipolar disorders and major depression. A life-long perspective. Eur Arch Psychiatry Clin Neurosci. 2003 Oct;253(5):236–40. doi: 10.1007/s00406-003-0437-2.
    1. Hollis C, Morriss R, Martin J, Amani S, Cotton R, Denis M, Lewis S. Technological innovations in mental healthcare: harnessing the digital revolution. Br J Psychiatry. 2015 May 02;206(4):263–5. doi: 10.1192/bjp.bp.113.142612.
    1. Jain SH, Powers BW, Hawkins JB, Brownstein JS. The digital phenotype. Nat Biotechnol. 2015 May 12;33(5):462–3. doi: 10.1038/nbt.3223.
    1. Insel TR. Digital Phenotyping: Technology for a New Science of Behavior. JAMA. 2017 Oct 03;318(13):1215–1216. doi: 10.1001/jama.2017.11295.
    1. Torous J, Onnela J, Keshavan M. New dimensions and new tools to realize the potential of RDoC: digital phenotyping via smartphones and connected devices. Transl Psychiatry. 2017 Mar 07;7(3):e1053–e1053. doi: 10.1038/tp.2017.25.
    1. Lee H, Lee H, Moon J, Lee T, Kim M, In H, Cho C, Kim L. Comparison of Wearable Activity Tracker with Actigraphy for Sleep Evaluation and Circadian Rest-Activity Rhythm Measurement in Healthy Young Adults. Psychiatry Investig. 2017 Mar;14(2):179–185. doi: 10.4306/pi.2017.14.2.179.
    1. Andersson G, Titov N. Advantages and limitations of Internet-based interventions for common mental disorders. World Psychiatry. 2014 Mar 04;13(1):4–11. doi: 10.1002/wps.20083. doi: 10.1002/wps.20083.
    1. Fairburn CG, Patel V. The impact of digital technology on psychological treatments and their dissemination. Behav Res Ther. 2017 Jan;88:19–25. doi: 10.1016/j.brat.2016.08.012.
    1. Sverdlov O, van Dam J, Hannesdottir K, Thornton-Wells T. Digital Therapeutics: An Integral Component of Digital Innovation in Drug Development. Clin Pharmacol Ther. 2018 Jul 23;104(1):72–80. doi: 10.1002/cpt.1036.
    1. Robillard R, Carpenter JS, Rogers NL, Fares S, Grierson AB, Hermens DF, Naismith SL, Mullin SJ, Feilds K, Glozier N, Scott EM, Hickie IB. Circadian rhythms and psychiatric profiles in young adults with unipolar depressive disorders. Transl Psychiatry. 2018 Oct 09;8(1):213. doi: 10.1038/s41398-018-0255-y.
    1. Takaesu Y. Circadian rhythm in bipolar disorder: A review of the literature. Psychiatry Clin Neurosci. 2018 Oct 04;72(9):673–682. doi: 10.1111/pcn.12688. doi: 10.1111/pcn.12688.
    1. Zaki NFW, Spence DW, BaHammam AS, Pandi-Perumal SR, Cardinali DP, Brown GM. Chronobiological theories of mood disorder. Eur Arch Psychiatry Clin Neurosci. 2018 Mar 11;268(2):107–118. doi: 10.1007/s00406-017-0835-5.
    1. Lee H. Circadian Misalignment and Bipolar Disorder. Chronobiol Med. 2019 Dec;1(4):132–136. doi: 10.33069/cim.2019.0027.
    1. Moon J, Cho C, Son GH, Geum D, Chung S, Kim H, Kang S, Park Y, Yoon H, Kim L, Jee H, An H, Kripke D, Lee H. Advanced circadian phase in mania and delayed circadian phase in mixed mania and depression returned to normal after treatment of bipolar disorder. EBioMedicine. 2016 Oct;11:285–295. doi: 10.1016/j.ebiom.2016.08.019.
    1. Doherty A. Circadian rhythms and mental health: wearable sensing at scale. Lancet Psychiatry. 2018 Jun;5(6):457–458. doi: 10.1016/S2215-0366(18)30172-X.
    1. Cho C, Lee T, Kim M, In HP, Kim L, Lee H. Mood Prediction of Patients With Mood Disorders by Machine Learning Using Passive Digital Phenotypes Based on the Circadian Rhythm: Prospective Observational Cohort Study. J Med Internet Res. 2019 Apr 17;21(4):e11029. doi: 10.2196/11029.
    1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders (DSM-5) United States: American Psychiatric Publishing; 2013. May 18, pp. 123–168.
    1. Cho C, Ahn Y, Kim SJ, Ha TH, Jeon HJ, Cha B, Moon E, Park DY, Baek JH, Kang H, Ryu V, An H, Lee H. Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study. Psychiatry Investig. 2017 Jan;14(1):100–106. doi: 10.4306/pi.2017.14.1.100.
    1. Halberg F, Tong Y, Johnson E. The Cellular Aspects of Biorhythms. Berlin/Heidelberg, Germany: Springer; 1967. Circadian System Phase — An Aspect of Temporal Morphology; Procedures and Illustrative Examples; pp. 20–48.
    1. Refinetti R, Lissen GC, Halberg F. Procedures for numerical analysis of circadian rhythms. Biol Rhythm Res. 2007 Aug;38(4):275–325. doi: 10.1080/09291010600903692.
    1. Glass RM. Treating depression as a recurrent or chronic disease. JAMA. 1999 Jan 06;281(1):83–4. doi: 10.1001/jama.281.1.83.
    1. Manji H, Lenox R. The nature of bipolar disorder. J Clin Psychiatry. 2000;61 Supp 13:42–57.
    1. Gitlin M, Frye MA. Maintenance therapies in bipolar disorders. Bipolar Disord. 2012 May;14 Suppl 2:51–65. doi: 10.1111/j.1399-5618.2012.00992.x.
    1. Kupfer DJ, Frank E, Perel JM, Cornes C, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1992 Oct 01;49(10):769–73. doi: 10.1001/archpsyc.1992.01820100013002.
    1. Frank E, Kupfer DJ, Thase ME, Mallinger AG, Swartz HA, Fagiolini AM, Grochocinski V, Houck P, Scott J, Thompson W, Monk T. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry. 2005 Oct 01;62(9):996–1004. doi: 10.1001/archpsyc.62.9.996.
    1. Kuyken W, Hayes R, Barrett B, Byng R, Dalgleish T, Kessler D, Lewis G, Watkins E, Morant N, Taylor RS, Byford S. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study) Health Technol Assess. 2015 Oct;19(73):1–124. doi: 10.3310/hta19730. doi: 10.3310/hta19730.
    1. Cho C, Lee H. Could Digital Therapeutics be a Game Changer in Psychiatry? Psychiatry Investig. 2019 Mar;16(2):97–98. doi: 10.30773/pi.2019.01.20.
    1. Felder JN, Epel ES, Neuhaus J, Krystal AD, Prather AA. Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant Women: A Randomized Clinical Trial. JAMA Psychiatry. 2020 Jan 22;77(5):484. doi: 10.1001/jamapsychiatry.2019.4491.
    1. Freeman D, Sheaves B, Goodwin GM, Yu L, Nickless A, Harrison PJ, Emsley R, Luik AI, Foster RG, Wadekar V, Hinds C, Gumley A, Jones R, Lightman S, Jones S, Bentall R, Kinderman P, Rowse G, Brugha T, Blagrove M, Gregory AM, Fleming L, Walklet E, Glazebrook C, Davies EB, Hollis C, Haddock G, John B, Coulson M, Fowler D, Pugh K, Cape J, Moseley P, Brown G, Hughes C, Obonsawin M, Coker S, Watkins E, Schwannauer M, MacMahon K, Siriwardena AN, Espie CA. The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis. The Lancet Psychiatry. 2017 Oct;4(10):749–758. doi: 10.1016/s2215-0366(17)30328-0.
    1. Scott J, Colom F, Pope M, Reinares M, Vieta E. The prognostic role of perceived criticism, medication adherence and family knowledge in bipolar disorders. Journal of Affective Disorders. 2012 Dec;142(1-3):72–76. doi: 10.1016/j.jad.2012.04.005.
    1. Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry. 2002 Dec;159(11):1927–9. doi: 10.1176/appi.ajp.159.11.1927.
    1. Rihmer Z. Prediction and prevention of suicide in mood disorders. European Psychiatry. 2008 Apr;23:S45. doi: 10.1016/j.eurpsy.2008.01.163.
    1. Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP. Can biological tests assist prediction of suicide in mood disorders? Int. J. Neuropsychopharm. 2005 Jun 21;9(04):465. doi: 10.1017/s1461145705005687.
    1. Whalley HC, Sussmann JE, Romaniuk L, Stewart T, Papmeyer M, Sprooten E, Hackett S, Hall J, Lawrie SM, McIntosh AM. Prediction of depression in individuals at high familial risk of mood disorders using functional magnetic resonance imaging. PLoS One. 2013 Mar 6;8(3):e57357. doi: 10.1371/journal.pone.0057357.
    1. Faurholt-Jepsen M, Busk J, Frost M, Vinberg M, Christensen EM, Winther O, Bardram JE, Kessing LV. Voice analysis as an objective state marker in bipolar disorder. Transl Psychiatry. 2016 Jul 19;6(7):e856–e856. doi: 10.1038/tp.2016.123.
    1. Vaci N, Liu Q, Kormilitzin A, De Crescenzo F, Kurtulmus A, Harvey J, O'Dell B, Innocent S, Tomlinson A, Cipriani A, Nevado-Holgado A. Natural language processing for structuring clinical text data on depression using UK-CRIS. Evid Based Ment Health. 2020 Mar 11;23(1):21–26. doi: 10.1136/ebmental-2019-300134.
    1. Perakslis ED. Using digital health to enable ethical health research in conflict and other humanitarian settings. Confl Health. 2018 May 14;12(1):23. doi: 10.1186/s13031-018-0163-z.
    1. Helbing D. Towards Digital Enlightenment. Berlin/Heidelberg, Germany: Springer; 2019. Societal, economic, ethical and legal challenges of the digital revolution: From big data to deep learning, artificial intelligence, and manipulative technologies; pp. 47–72.
    1. Monroe CM. Valuable steps ahead: promoting physical activity with wearables and incentives. The Lancet Diabetes & Endocrinology. 2016 Dec;4(12):960–961. doi: 10.1016/s2213-8587(16)30264-9.
    1. Asimakopoulos S, Asimakopoulos G, Spillers F. Motivation and User Engagement in Fitness Tracking: Heuristics for Mobile Healthcare Wearables. Informatics. 2017 Jan 22;4(1):5. doi: 10.3390/informatics4010005.
    1. Jakicic JM, Davis KK, Rogers RJ, King WC, Marcus MD, Helsel D, Rickman AD, Wahed AS, Belle SH. Effect of Wearable Technology Combined With a Lifestyle Intervention on Long-term Weight Loss: The IDEA Randomized Clinical Trial. JAMA. 2016 Oct 20;316(11):1161–1171. doi: 10.1001/jama.2016.12858.

Source: PubMed

3
订阅